Hormaomycin analogues by precursor-directed biosynthesis - Synthesis of and feeding experiments with amino acids related to the unique 3-(trans-2′- nitrocyclopropyl)alanine constituent

European Journal of Organic Chemistry

Volumn , Issue 5, 2005, Pages 854-863

  Kozhushkov, Sergei I ^a   Zlatopolskiy, Boris D ^a   Brandl, Melanie ^a   Alvermann, Petra ^a   Radzom, Markus ^a   Geers, Bernardette ^a   De Meijere, Armin ^a   Zeeck, Axel ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Aldol reactions; Amino acids; Biosynthesis; Hormaomycin; Isotopic labeling; Natural products; Synthetic methods

Indexed keywords

3 (2' AMINOCYCLOPROPYL)ALANINE; 3 (2' NITROCYCLOPROPYL)ALANINE; 3 [2 (HYDROXYCARBONYL)CYCLOPROPYL]ALANINE; 3 [2 (METHOXYCARBONYL)CYCLOPROPYL]ALANINE; DEUTERIUM; GLYCINE DERIVATIVE; HORMAOMYCIN; LACTONE; LITHIUM DERIVATIVE; NATURAL PRODUCT; NORVALINE; PEPTIDE; TERT BUTYL (DIPHENYLMETHYLENE)AMINOACETATE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; COVALENT BOND; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME SPECIFICITY; HYDROGENATION; NONHUMAN; REACTION ANALYSIS; STREPTOMYCES; STREPTOMYCES GRISEOFLAVUS; STRUCTURE ANALYSIS;

EID: 15044338608     PISSN: 1434193X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ejoc.200400608     Document Type: Article

References (60)

1. Isolation and properties: a) N. Andres, H. Wolf, H. Zähner, E. Rössner, A. Zeeck, W. A. König, V. Sinnwell, Helv. Chim. Acta 1989, 72, 426-437;
2. b) E. Rössner, A. Zeeck, W. A. König, Angew. Chem. 1990, 102, 84-85; Angew. Chem. Int. Ed. Engl. 1990, 29, 64-65;
3. b) E. Rössner, A. Zeeck, W. A. König, Angew. Chem. 1990, 102, 84-85; Angew. Chem. Int. Ed. Engl. 1990, 29, 64-65;
4. c) K. Otoguro, H. Ui, A. Ishiyama, N. Arai, M. Kobayashi, Y. Takahashi, R. Masuma, K. Shiomi, H. Yamada, S. Omura, J. Antibiotics 2003, 56, 322-324.
5. For the total synthesis see: d) B. D. Zlatopolskiy, A. de Meijere, Chem. Eur. J. 2004, 10, 4718-4727.
6. Final structure elucidation: e) B. Zlatopolskiy, K. Loscha, P. Alvermann, S. I. Kozhushkov, S. V. Nikolaev, A. Zeeck, A. de Meijere, Chem. Eur. J. 2004, 10, 4708-4717.
7. The formula of 1a as presented here and in these previous publications do depict the correct configuration in the (S)-isoleucine (He) moiety. The formulas in our recently published "Corrigendum" (see Chem. Eur. J. 2004, 10, 5568) were indeed erroneous in this respect.
8. Isolation and properties: a) A. Asai, A. Hasegawa, K. Ochiai, Y. Yamashita, T. Mizukami, J. Antibiotics 2000, 53, 81-83;
9. b) H. Yamaguchi, A. Asai, T. Mizukami, Y. Yamashita, S. Akinaga, S.-i. Ikeda, Y. Kanda, Eur. Patent 1, 166, 781 A1 2000; Chem. Abstr. 2000, 133, 751;
10. c) A. Asai, T. Tsujita, S. V. Sharma, Y. Yamashita, S. Akinaga, M. Funakoshi, H. Kobayashi, T. Mizukami, M.-s. Asahi-machi, Biochem. Pharmacol. 2004, 67, 227-234.
11. Total synthesis of belactosin A: d) O. V. Larionov, A. de Meijere, Org. Lett. 2004, 6, 2153-2156;
12. e) A. Armstrong, J. N. Scutt, Chem. Commun. 2004, 510-511.
13. Preparations of the non-labeled enantiomerically pure 3-(trans-2′-nitrocyclopropyl)alanines (3): a) O. V. Larionov, T. F. Savelieva, K. A. Kochetkov, N. S. Ikonnokov, S. I. Kozhushkov, D. S. Yufit, J. A. K. Howard, V. N. Khrustalev, Yu. N. Belokon, A. de Meijere, Eur. J. Org. Chem. 2003, 869-877.
14. For the synthesis of enantiomerically pure mixtures of epimers of 3 see also: b) J. Zindel, A. Zeeck, W. A. König, A. de Meijere, Tetrahedron Lett. 1993, 34, 1917-1920;
15. c) J. Zindel, A. de Meijere, Synthesis 1994, 190-194;
16. d) J. Zindel, A. de Meijere, J. Org. Chem. 1995, 60, 2968-2973;
17. e) J. Zindel, Dissertation, University of Göttingen, 1993.
18. Preliminary communication: a) M. Brandi, S. I. Kozhushkov, K. Loscha, O. V. Kokoreva, D. S. Yufit, J. A. K. Howard, A. de Meijere, Synlett 2000, 1741-1744.
19. This strategy was recently applied for the preparation of enantiomerically pure 4, which in turn was used in the total synthesis of 2 (see ref. [2e]); b) A. Armstrong, J. N. Scutt, Org. Lett. 2003, 5, 2331-2334.
20. For an alternative approach to 4 see also: c) O. V. Larionov, S. I. Kozhushkov, M. Brandl, A. de Meijere, Mendeleev Commun. 2003, 199-200.
21. The amino acid 5 has previously been prepared in four steps starting from 2-amino-4-pentenoic acid with an overall yield of only 44%. It has been shown to be a selective partial agonist of the N-methyl-D-aspartate (NMDA) receptor site: R. Pellicciari, B. Natalini, M. Marinozzi, B. M. Sadeghpour, A. A. Cordi, T. H. Lanthorn, W. F. Hood, J. B. Monahan, Farmaco 1991, 46, 1243-1264.
22. a) C. Hamon, B. J. Rawlings, Synth. Commun. 1996, 26, 1109-1116, and references cited therein.
23. This compound was prepared by alkylation of the lithiated O'Donnel's glycine equivalent 11 with iodomethylcyclopropane followed by acid-catalyzed deprotection, see also: b) E. J. Corey, F. Xu, M. C. Noe, J. Am. Chem. Soc. 1997, 119, 12414-12415;
24. c) D. Tzalis, P. Knochel, Tetrahedron Lett. 1999, 40, 3685-3688.
25. E. J. Corey, S. G. Pyne, W. Su, Tetrahedron Lett. 1983, 24, 4883-4886.
26. a) M. J. O'Donnell, R. L. Polt, J. Org. Chem. 1982, 47, 2663-2666;
27. b) for recent reviews see: M. J. O'Donnell, Aldrichimica Acta 2001, 34, 3-15, and ref.[3] cited therein.
28. Several of the conceivable approaches to 4 such as the Curtius degradation of protected 3-(trans-2-hydroxycarbonylcyclopropyl)alanine as well as substitution of the 3-[trans-2-(tert-butoxycarbonyl)aminocyclopropyl]methanol tosylate with the nucleophilic O'Donnell glycine equivalent 11 were tested without any success. The starting materials for these attempted transformations were prepared from dimethyl trans-1,2-cyclopropanedicarboxylate according to published procedures. Cf. a) R. Csuk, Y. v. Scholz, Tetrahedron 1995, 51, 7193-7206;
29. b) R. Csuk, Y v. Scholz, Tetrahedron 1994, 50, 10431-10442.
30. a) M. Coblentz, J. Royer, J. Dreux, Bull. Soc. Chim. Fr. 1963, 1279-1280;
31. b) N. Miyashita, A. Yoshikoshi, P. A. Greico, J. Org. Chem. 1977, 42, 3772-3774;
32. c) G. Kokotos, J. M. Padron, T. Martin, W. A. Gibbons, V. S. Martin, J. Org. Chem. 1998, 63, 3741-3744;
33. d) G. Bold, H. Steiner, L. Moesch, B. Walliser, Helv. Chim. Acta 1990, 73, 405-410.
34. a) S. P. Schmidt, D. W. Brooks, Tetrahedron Lett. 1987, 28, 767-768;
35. b) A. Martinez-Grau, D. P. Curran, Tetrahedron 1997, 53, 5679-5698;
36. c) D. P. Curran, J. Xu, E. Lazzarini, J. Chem. Soc. Perkin Trans. 1 Chem. Soc. Perkin Trans, 1 1995, 3049-3060;
37. d) M. Lautens, S. Kumanovic, J. Am. Chem. Soc. 1995, 117, 1954-1964.
38. J. E. Baldwin, G. E. C. Chang, Tetrahedron 1982, 38, 825-835.
39. M. Brandl, S. I. Kozhushkov, B. Zlatopolskiy, P. Alvermann, B. Geers, A. Zeeck, A. de Meijere, Eur. J. Org. Chem. 2005, 123-135.
40. For experimental details see: P. Alvermann, Dissertation, University of Göttingen, 2001.
41. H. von Döhren, U. Keller, J. Vater, R. Zocher, Chem. Rev. 1997, 97, 2675-2705.
42. B. Zlatopolskiy, M. Radzom, A. Zeeck, A. de Meijere, Eur. J. Org. Chem., manuscript submitted.
43. 1H-NMR spectra. Moreover, at least for one hormaomycin analogue, 1H-NMR spectra measured with the same spectrometer, in the same solvent, at the same temperature, and from the same sample showed distinct differences. See ref.[1d] for a deeper discussion.
44. a) A. L. J. Beckwith, K. U. Ingold, in: Rearrangements in Ground and Excited States, vol. 1 (Ed.: P. de Mayo), Academic Press, New York, 1980, pp. 161-310;
45. b) J. C. Walton, in Methods of Organic Chemistry (Houben-Weyl), vol. E17c (Ed.: A. de Meijere), Thieme, Stuttgart, 1997, pp. 2438-2525.
46. a) D. Wendisch, in: Methoden der Organischen Chemie (Houben-Weyl), vol. 4/3 (Ed.: E. Müller), Thieme, Stuttgart, 1971, pp. 399-405;
47. c) G. Boche, H. M. Walborsky, Cyclopropane-Derived Reactive Intermediates (Eds.: S. Patai, Z. Rappoport), Wiley, Chichester, 1990, and references therein.
48. a) M.-t. Lai, L.-d. Liu, H.-w. Liu, J. Am. Chem. Soc. 1991, 113, 7388-7397;
49. b) M.-t. Lai, H.-w. Liu, J. Am. Chem. Soc. 1992, 114, 3160-3162.
50. M. A. Marahiel, T. Stachelhaus, H. D. Mootz, Chem. Rev. 1997, 97, 2651-2673.
51. In the radical homoallylic rearrangement of hypoglycine A the arising intermediate inactivates general Acyl-CoA Dehydrogenase, see ref.[20]
52. U. M. Reinscheid, B. D. Zlatopolskiy, A. Zeeck, C. Griesinger, A. de Meijere, Chem. Eur. J., in press.
53. For the synthesis of the starting di- and monomethyl esters of trans-cyclopropane-1,2-dicarboxylic acid, the protocol of Csuk et al. (ref.[9b]) was used. See also: K. M. Edvinsson, M. Hersloef, P. Holm, N. Kann, D. J. Keeling, J. P. Mattsson, B. Norden, V. Shcherbukhin, Bioorg. Med. Chem. Lett. 2000, 10, 503-508.
54. a) For spectroscopic and analytical data of the non-deuterated compound see refs.[3d,4];
55. b) for another method of preparation of a non-deuterated compound see also: L. Dechoux, E. Doris, Tetrahedron Lett. 1994, 35, 2017-2020.
56. a) For spectroscopic and analytical data of the non-deuterated compound see refs.[3e,9a];
57. b) for another method of preparation of the non-deuterated compound see refs.[9a,9b]
58. For spectroscopic and analytical data of the non-deuterated compound see ref.[3a]
59. For spectroscopic and analytical data of the non-deuterated compound see Supporting Information in ref.[4b]
60. For spectroscopic and analytical data of the non-deuterated compound see ref.[4c] and Supporting Information in ref.[4b]